STOCK TITAN

[6-K] Curaleaf Holdings, Inc. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Analyzing...
Positive
  • None.
Negative
  • None.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of September, 2025
Commission File Number: 333-249081
Curaleaf Holdings, Inc.
(Name of Registrant)
666 Burrard Street, Suite 1700,
Vancouver, British Columbia V6C 2X8, Canada
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☐    Form 40-F ☒



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CURALEAF HOLDINGS, INC.
(Registrant)
Date:September 25, 2025By:/s/ Peter Clateman
Name:Peter Clateman
Title:Chief Legal Officer



EXHIBIT INDEX

Exhibit NumberDescription
99.1
Press Release

Curaleaf Hldgs

OTC:CURLF

CURLF Rankings

CURLF Latest News

CURLF Stock Data

1.94B
616.07M
27.84%
2.12%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Stamford